Works citing this work

2 works

Work: Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia

1. Neurological complications after covid-19 vaccination

   K. Khalimova, Nilufar Rashidova, Javlon Salimjonov

   ArticleSARS-CoV-2 and COVID-19 ResearchS S Korsakov Journal of Neurology and Psychiatry20230 citations

   ABIABI:AkademIndex/openalex/2023.article.012313

2. Neurological Complications after COVID-19 Vaccination

   K. Khalimova, Nilufar Rashidova, Javlon Salimjonov

   ArticlePeripheral Neuropathies and DisordersNeuroscience and Behavioral Physiology20240 citations

   ABIABI:AkademIndex/openalex/2024.article.006492